Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
4.330
-0.120 (-2.70%)
At close: Jul 24, 2026, 4:00 PM EDT
4.340
+0.010 (0.23%)
Pre-market: Jul 27, 2026, 5:44 AM EDT
Zentalis Pharmaceuticals Employees
Zentalis Pharmaceuticals had 106 employees as of December 31, 2025. The number of employees decreased by 60 or -36.14% compared to the previous year.
Employees
106
Change (1Y)
-60
Growth (1Y)
-36.14%
Revenue / Employee
n/a
Profits / Employee
-$1,171,066
Market Cap
308.24M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 106 | -60 | -36.14% |
| Dec 31, 2024 | 166 | -2 | -1.19% |
| Dec 31, 2023 | 168 | 12 | 7.69% |
| Dec 31, 2022 | 156 | -21 | -11.86% |
| Dec 31, 2021 | 177 | 53 | 42.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Lyell Immunopharma | 161 |
| Fate Therapeutics | 161 |
| Foghorn Therapeutics | 106 |
| Neumora Therapeutics | 92 |
| OmniAb | 89 |
| Immuneering | 55 |
| Vicore Pharma Holding AB | 40 |
ZNTL News
- 3 days ago - Zentalis initiated with a Buy at Rodman & Renshaw - TheFly
- 9 days ago - Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026 - GlobeNewsWire
- 10 days ago - Zentalis initiated with an Outperform at Mizuho - TheFly
- 5 weeks ago - Zentalis assumed with an Outperform at Oppenheimer - TheFly
- 7 weeks ago - Zentalis Pharmaceuticals Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Zentalis Strengthens Commercial Leadership with Appointments of Shannon Campbell to Board of Directors and Sarah Kelly as SVP of Commercial Strategy - GlobeNewsWire
- 2 months ago - Zentalis Pharmaceuticals Proxy statement: Proxy filing - Filings